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R.Cerio el al.
There is increasing phenotypic and functional evidence for the recognition of several dendritic antigen-presenting cells (APC) which are both lymphoid and non-lymphoid associated. Well characterized lymphoid APCs include dendritic reticulum cells, interdigitating dendritic cells' and follicular dendritic cells.^ Circulating immunocompetent dendritic cells have also been found in human peripheral blood'"* and afferent lymph.^ Non-lymphoid immunocompetem dendritic cells include Langerhans cells,'' collagen associated dendritic cells ' as well as dendritic cells in the synovium,** respiratory tract,^*^ thyroid gland^' and heart.'^ It has been suggested that macrophages and dendritic cells have a common origin in the human yolk sac but diverge early in foetal development.' •' Activation and proliferation of antigen-specific effector T cells are dependent upon recognition of antigens by APC which bear class II major histocompatibility complex (MHC) antigens. These can be expressed on both epidermal and dermal cells including Langerhans cells,'' endothelial cells/'* B cells,'"^ melanophagcs,'""'" as well as dermal'^'^" and other dendritic cells.^^^-^T he derivation and role of the DR* dermal dendritic cell is still uncertain. Using enzyme histochemical and immunochemical techniques it has been shown that many dermal dendritic cells share features with mononuclear phagocytic cells (macrophages) and have a phagocytic function.^ In addition, as in humans, class II MHC bearing dermal cells distinct from endothelial cells are present in mouse skin, and function as APCs in vitro and initiate primary contact hypersensitivity responses to contact allergens.'^'^R ecently, there has been renewed interest in the cytoplasmic identification of the subunit A of the clotting proenzyme factor XIII (FXIIIa). The protein is expressed in histiocytic reticulum cells (sinus lining cells) of lymphoid tissue,^"* peripheral blood monocytes,^''"**' peritoneal macrophages,^^ reactive fibroblasts,-^^ and recently in dermal dendritic cells.-^ Nemes el al.^r egard this protein as a marker of phagocytic function.
The aim of this study was to further characterize FXIIIa positive dendritic cells in normal and inflamed human cutaneous tissue using immunocytochemical techniques. We have investigated the lineage of FXIIIa positive dermal dendritic cells including their relationship to Langerhans cells and monocyte/macrophages, and also whether these cells could be stimulated by gamma interferon (IFN-y) to express intercellular adhesion molecule-1 (ICAM-i) or CDi. We also looked at the role of FXIIIa' cells in infiammatory dermatoses.
METHODS
Skin biopsies
Six normal neonatal foreskins were obtained at routine circumcision. Punch biopsies of skin (6 mm) were performed on three healthy volunteers and on lesional skin from patients with chronic plaque-type psoriasis (8) and atopic eczema (io).
Specimens from both foreskin and adult skin biopsies were divided into 2-mm portions. One portion was embedded in gum tragacanth (Sigma Chemical Co., St Louis, MO, U.S.A.), mounted on cork and frozen in isopentane, cooled in liquid nitrogen, and stored, wrapped in aluminium foil at -yo'^C until use. Other divided portions were incubated in 5 ml of Dulbecco's modified Eagle's medium (Gibco Laboratories, Grand Island, NY, U.S.A.) supplemented with 10% heat-inactivated fetal calf serum (Gibco Laboratories) either alone or with recombinant IFN-y (Dr M. Shephard, Genentech Inc., San Francisco, CA, U.S.A.) (specific activation-I "7 X 10 U/mg, normal concentration of 1200 /i/ml). Incubated specimens were maintained with periodic agitation in a humidified incubator with 5% CO2/95% air at 37°C for 48 h, then embedded as described above.
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Double immunofluorescence labelling
Five micron cryostat sections were cut and air-dried. A panel of antibodies to various human mononuclear cell types was employed in an indirect immunofluorescence labelling technique (Table i) . Skin sections were incubated with primary antibodies for 45 min followed by three 5-min washes in phosphate-buffered saline (PBS). Second-step staining was performed with the use of goat anti-mouse IgG (1/40) (heavy-and light-chain-spccific-affinity purified, humanserum absorbed and fluorescein conjugated; Kirkegaard and Perry, Gaithersburg, MD, U.S.A.) for 30 min. Labelling for detection of polyclonal rabbit anti-FXIIIa or factor VIII (FVIII) related antigen (1/40) and mouse monoclonal antibodies (1/20) was accomplished using rhodamine on fluorescein-conjugated goat anti-rabbit IgG (1/20) (Tago Inc., Burligamej CA, U.S.A.) in a similar manner. Endothelial cells were visualized with a directly fluoresceinconjugated goat anti-human factor VIII related antigen (Atlantic Antibodies, Scarborough, ME, U.S.A.). Double-labelling immunofluorescence microscopy was performed by visualizing bound antibody against FXIIIa with fluorescein-conjugated F(ab)2 goat anti-rabbit IgG (Tago Inc.) followed by mouse monoclonal antibody and normal rabbit IgG to block cross-reactivity of the conjugated antibodies; the mouse antibody then being visualized with rhodamine-conjugated goat anti-mouse IgG. (Cappel Laboratories, Cockranville, PA, U.S.A.)-Control sections were incubated in normal rabbit serum instead of primary polyclonal antibody and in mouse serum instead of monoclonal antibodies to verify the absence of xerogenic cross reactivity of the conjugated antibodies. Mast cells were visualized using avidin-conjugated to fluorescein. All dilutions were made up in PBS with io",, fetal calf serum.
Evaluation of fluorescence was performed with a Nikon microscope equipped with epifluorescence and appropriate filters. Identical fields were photographed and the percentage of each cell marker was analysed against labelling with FXIIIa. 
Immunoperoxidase labelling
Fresh frozen cryostat sections (5 /(m) were cut and dried and fixed in acetone at 4 C for 10 min. Staining was accomplished with an avidin-biotin peroxidasc technique (Vectastain ABC mouse kit-Vector Labs., Inc., Burlingame, CA, U.S.A.) employing the monoclonal antibodies listed in Table i . The optimal concentrations of these monoclonal antibodies were determined to provide maximal specific labelling with minimal non-specific or background staining (data not shown). Either 3,3'-diaminobenzidenc tetrahydrochloride or 3-amino-9-ethycarbazole were used as the chromogen. The sections were counterstained in i",, haematoxylin. FXIIIa was also identified in routine paraffin-processed specimens. Sections were de-waxed in xylene, followed by rehydration in graded alcohols. Subsequently, slides were trypsinized (trypsin [Sigma, St. Louis, MO, U.S.A.] o-i",, in o i"o CaClj in distilled water, pH 78 for 10 min at 37'C) and treated with os",, H2O2 in absolute methanol for 30 min to block endogenous peroxidase activity. The sections were then labelled in the same way as cryostat specimens employing a Vectastain ABC rabbit kit. The primary FXIIIa rabbit antibody was applied at a dilution of 1/ 200-1/400.
RESULTS
Normal skin
FXIIIa ^ dermal dendritic cells could be demonstrated in both neonatal foreskin and adult skin. They were distributed mainly in the upper dermis but especially in the papillary dermis around superficial blood vessels (Fig. i) . No labelling was seen in the epidermis in normal skin, nor in adnexal structures or neural tissue.
To determine the derivation of FXIIIa' cells in the dermis, double immunofluorescence labelling was carried out in both neonatal and adult skin with similar results. FXIIIa was not expressed by endotheiial cells expressing FVIII related antigen (Fig. 2) , or by fibroblasts expressing Te7 or by mast cells visualized by avidin-binding. However, 87";, of FXIIIa '' cells expressed the bone marrow derivation marker HLc-i. This was supported by HLe-i immunoperoxidase labelling of dermal dendritic cells (Fig. 3) . Among bone marrow-derived cells FXIIIa' cells failed to express T lymphocyte (CD2) or Langerhans cell (CDi) markers (Fig. 4) , but S5'\> did express HLA-DR (Fig. 5) , LFA-i and 48",, HLA-DQ, suggesting a OKM5 is also expressed on some FVIII related antigen-positive endothelial cells in skin,'** raising the possibility of overlap between FXIIIa * ,OKM5" cells and FVIII' endothelial cells. However, notallOKM5 ' cells expressed FXIIIa and none of the FVIII ^ endothelial cells were identified as positive for FXIIIa, indicating that OKM5 is expressed on at least two separate types of dermal cells.
These findings were confirmed using immunoperoxidasc single-labelling techniques in cryostat sections of normal skin.
Inflamed skin
FXIIIa labelling of skin from benign inflammatory dermatoses such as atopic eczema and psoriasis compared to normal skin revealed an increase in the number of dermal dendritic cells. Numerous FXIIIa dendritic cells were demonstrated around superficial blood vessels particularly in atopic eczema (Fig. 6) . In contrast to normal skin, foci of FXIIIa ' dendritic cells were observed in the epidermis associated with lymphocytes, especially where spongiosis and vesicle formation were most evident (Fig. 7) . In skin from patients with chronic plaque psoriasis the increase in FXIIIa ^ cells appeared to be confined to the papillary dermis, and in two cases dendritic processes from FXIIIa^ cells were observed traversing the basement membrane into the epidermis, closely associated with inflammatory cells (Fig. 8) . Individual positively labelled cells were also seen in the epidermis which appeared to originate from the dilated papillary blood vessels. In normal neonatal foreskin and adult skin in the modified organ culture system, ICAM-i expression was confined to endothelial cells but when stimulated with IFN-7, ICAM-i was found to be induced on FXIIIa' dermal dendritic cells. Furthermore, there appeared to be increased expression of HLA-DR on these cells, although this was not quantified. DISCUSSION The findings in this study confirm the previous suggestion that FXIIIa is a cell marker for dermal dendrocytes,^'^"'' and provide phenotypic and functional evidence for the characterization of a bone marrow-derived HLA-DR^ dermal dendritic cell population, distinct from Langerhans cells. In contrast to Langerhans cells they lack CDi and have been shown to be phagocytic.^' Unlike previous reports^^ we have shown that in cutaneous tissue, FXIIIa^ cells are not fibroblasts (i.e. Te7") which agrees with the recent report of negative FXIIIa labelling in fibrocollagenous cutaneous disorders.^^ FXIIIa^ cells are bone marrow-derived cells with some of the cell surface antigens found on monocyte/macrophage subsets (OKM5^, Mo i^, Mono I*, Leu M3 + ).
We suggest that FXIIIa"^ OKMs'^ dermal dendritic cells comprise a pluripotential population, capable under various circumstances of macrophage effector functions,"'"'" APC functions,'^'^^'^'^^ and perhaps even differentiation into Langerhans cells upon migration into the epidermis.^'* Recently, Weiss et al.^^ have shown that dermal phagocytic cells, containing melanin, in inflammatory skin diseases demonstrate the surface phenotype of CDi^DR*^, OKM5 + , OKMi", APC's and activated macrophages (Mo3^). These OKMs"^ dermal dendritic melanophages may represent the same subtype as detected by FXIIIa and may derive Factor Xllla* dermal dentritic cells 429 from them. Moreover, CD i " DR ^, OKM5 *, OKMi" melanophages have been demonstrated in humati epidermis after ultraviolet light exposure and have been shown to have potent APC activity.'*" The FXIIIa^ dermal dendritic cells appear distinct however, in that they express Leu M3 and Moi, whereas CDi"DR^ OKM5 ' epidermal melanophages lack these two cell surface antigens.'^ Similarly, increased CDi "DR* subpopulations of epidermal cells have been demonstrated in psoriasis^^^'^*' and recently, other inflammatory dermatoses.^^'^^ Ultrastructural studies have suggested that at least some of the CD i ' DR ^ epidermal dendritic cells were of the Langerhans cell lineage. Our studies have shown that FXIIIa^ dermal dendritic cells can be induced by IFN-y to co-express ICAM-i. In inflamed skin such as atopic eczema and psoriasis, FXIIIa^ cells appear to migrate from the papillary dermis into the epidermis in close proximity to lymphocytes and other inflammatory cells, probably by virtue of their ICAM-i positivity. We propose that some of the CDi DR*^ epidermal dendritic cells arc FXIIIa^. In UV-induced inflammation the CDi DR + , OKM5 \ OKMi melanophages exhibited the capacity to present antigen and to activate autologous T cells in the absence of added antigens.'* Our immunophenotypic characterization suggests that FXIIIa^ dermal dendritic cells may represent the cutaneous analogue of potent blood APC, described as a minor subsetof monocytes witha phenotypeOKMs^ OKMi ~ }^ These cells may be responsible in a similar way for stimulating immunoregulatory T cells that modulate other immune responses.^^"^^ If FXIIIa^, Class II MHC bearing dermal dendritic cells are analogous to murine Class 11 MHC dermal dendritic cells, then they would be expected to process and present soluble and alloantigens to T cells'^ and to be able to initiate allergic contact hypersensitivity responses.^" Expression of the antigen detected by OKM5 has also been shown on endothelial cells'** suggesting that FXIIIa might also be identified in endothelial cells. However, double staining studies with antifactor VIII related antigen showed that as with OKM5 ^ melanophages, these bone marrow derived cells are distinct from endothelial cells."* Functional studies with the modified organ skin culture**' showed that when stimulated by IFN-y, FXIIIa positive dermal cells demonstrate increased expression of ICAM-i. The latter is an inducible glycoprotein found on vascular endothelial cells, mitogen-stimulated T lymphocytes, EBV transformed B cells and tissue macrophages*^ and is important for leucocyte trafficking into tissues.*"* ICAM-i is the ligand for lymphocyte function associated antigen-i (LFA-i) found on lymphocytes and monocytes. The expression of ICAM-t by the dermal dendrocyte may facilitate adhesive interactions with T lymphocytes as we have proposed for keratinocyte lymphocyte reaction.*'*"^ We have recently labelled fixed and unfixed cultured human fibroblasts for LFA-i and FXIIIa and there was no cell surface immunolabelling. Also, fibroblasts are LFA-3 positive but neither LFA-i nor FXIIIa could be induced on fibroblasts with either IFN-y or IFN-a.
In conclusion, FXIIIa' dendritic cells in normal skin and in some examples of inflammatory cutaneous diseases represent a specific immunological cell population with multiple potential functional properties as defined by their immunophenotype. Moreover, cytoplasmic FXIIIa can be detected in routine paraflin-embedded sections allowing superior preservation of morphological detail which permits a retrospective study of this cell marker in a wide spectrum of cutaneous diseases. There is evidence to support the hypothesis that dermal dendritic cells, or important subsets thereof, constitute an immunologically competent cell population which is indigenous to the dermis if not to all collagen-rich tissues.
•''•^' It would be reasonable for dermal immunologic competence to be complementary to epidermal immunologic function, particularly in a wide variety of immunologically mediated inflammatory dermatoses. Recently, we have reported that FXIIIa' dermal dendritic cells are increased in a wide variety of inflammatory, fibrohistiocytic and granulomatous dermatoses including AIDS-associated Kaposi's sarcoma also suggesting that these cells have an important role in the pathophysiology of these disorders.***^A CKNOWLEDGMENTS RC and CEMG were partially supported by travelling fellowships from the British Association of Dermatologists. KDC was supported in part by NIH grant No. K08AR01770-03, the Veterans Administration Medical Research Service and BJN by NIH grant No. AR389570.
